San Francisco, United States
Log10.io, founded in 2023, is a promising player in the AI and Data Analytics industries, headquartered in the United States. The company's flagship product, Everest, is a cutting-edge AI platform tailored for medical writing. It aims to revolutionize the way clinical, regulatory, and strategic documentation is produced across the life sciences sector. By enabling CROs, consultancies, and life sciences teams to quickly generate regulatory-ready documents—from trial protocols to global submissions—Everest significantly enhances operational efficiency, allowing teams to deliver more without expanding their workforce.
The team behind Log10.io is composed of AI experts dedicated to refining large language models for high-stakes, enterprise-ready applications where accuracy and auditability are crucial. Recently, the company secured a $7.20M Seed Round investment on 24 April 2024, with contributions from prominent investors such as Essence VC, Quiet Capital, and TQ Ventures. This investment underscores confidence in Log10.io's potential to transform medical documentation processes.
